Descriptor English: | Prostaglandins F | ||||||
Descriptor Spanish: |
Prostaglandinas F
| ||||||
Descriptor Portuguese: | Prostaglandinas F | ||||||
Descriptor French: | Prostaglandines F | ||||||
Entry term(s): |
PGF |
||||||
Tree number(s): |
D10.251.355.255.550.400 D23.469.050.175.725.400 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D011460 | ||||||
Scope note: | (9 alpha,11 alpha,13E,15S)-9,11,15-Trihydroxyprost-13-en-1-oic acid (PGF(1 alpha)); (5Z,9 alpha,11,alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid (PGF(2 alpha)); (5Z,9 alpha,11 alpha,13E,15S,17Z)-9,11,15-trihydroxyprosta-5,13,17-trien-1-oic acid (PGF(3 alpha)). A family of prostaglandins that includes three of the six naturally occurring prostaglandins. All naturally occurring PGF have an alpha configuration at the 9-carbon position. They stimulate uterine and bronchial smooth muscle and are often used as oxytocics. |
||||||
Annotation: | /chem syn permitted: do not convert to PROSTAGLANDINS F, SYNTHETIC |
||||||
Allowable Qualifiers: |
AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Entry Combination: |
analogs & derivatives:Prostaglandins F, Synthetic
|
||||||
Previous Indexing: |
Prostaglandins (1966-1974) |
||||||
Public MeSH Note: | 75 |
||||||
History Note: | 75 |
||||||
DeCS ID: | 11893 | ||||||
Unique ID: | D011460 | ||||||
NLM Classification: | QU 91 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1975/09/01 | ||||||
Date of Entry: | 1974/11/11 | ||||||
Revision Date: | 2016/06/28 |
-
-
CHEMICALS AND DRUGS
Lipids [D10]Lipids -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors
|
Prostaglandins F
- Preferred
Concept UI |
M0017812 |
Scope note | (9 alpha,11 alpha,13E,15S)-9,11,15-Trihydroxyprost-13-en-1-oic acid (PGF(1 alpha)); (5Z,9 alpha,11,alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid (PGF(2 alpha)); (5Z,9 alpha,11 alpha,13E,15S,17Z)-9,11,15-trihydroxyprosta-5,13,17-trien-1-oic acid (PGF(3 alpha)). A family of prostaglandins that includes three of the six naturally occurring prostaglandins. All naturally occurring PGF have an alpha configuration at the 9-carbon position. They stimulate uterine and bronchial smooth muscle and are often used as oxytocics. |
Preferred term | Prostaglandins F |
Entry term(s) |
PGF |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey